Johannes Spleiss

Title: Innovations by Johannes Spleiss in Pharmaceutical Composition

Introduction

Johannes Spleiss is an accomplished inventor based in Ziefen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of soft gelatin encapsulated compositions. His work focuses on enhancing the stability and efficacy of essential fatty acids in pharmaceutical formulations.

Latest Patents

Johannes Spleiss holds a patent for a unique pharmaceutical composition that includes cis-5,8,11,14,17-eicosapentaenoic acid and cis-7,10,13,16,19-docosapentaenoic acid in free acid form. The patent details a formulation where the soft gelatin capsules are designed to improve shelf life by incorporating a specific ratio of these fatty acids. This innovation is crucial for ensuring the effectiveness of the encapsulated compounds over time.

Career Highlights

Throughout his career, Johannes Spleiss has been associated with Chrysalis Pharma AG, where he has played a pivotal role in advancing pharmaceutical technologies. His expertise in the formulation of soft gelatin capsules has positioned him as a key figure in the industry. With a focus on quality and innovation, he continues to contribute to the development of effective pharmaceutical products.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Johannes Spleiss is a notable inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. His innovative approach to encapsulating essential fatty acids demonstrates his commitment to enhancing drug formulations.